Published in Cancer Weekly, December 16th, 1996
GenSENSE is a program designed to make advanced risk assessment tools more accessible to individual physicians and their patients at risk for developing inherited cancers. GenSENSE is comprised of three easy-to-use components to determine if a patient's family history signals an increased risk of cancer.
The confidential program begins with GenSTART, a short questionnaire designed for patients to complete in the physician's waiting room. If the brief history suggests a potential pattern of familial cancer, the physician may recommend the patient complete a more...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.